학술논문
Technetium-99m (Tc)-labelled sulesomab in the management of malignant external otitis: is there any role?
Document Type
Article
Author
Source
Subject
*TECHNETIUM
*OTITIS treatment
*DISEASE management
*FOLLOW-up studies (Medicine)
*ANTIBIOTICS
*TREATMENT effectiveness
*THERAPEUTICS
*
*
*
*
*
*
Language
ISSN
0937-4477
Abstract
We report two cases of malignant external otitis (MEO) evaluated with Technetium-99m(Tc)-labelled sulesomab. Two patients affected by MEO are presented, together with a literature review. Both patients were studied with clinical examination, ear discharge culture, radiological imaging, blood exams, Tc Sulesomab, and treated with antibiotic therapy. Tc-Sulesomab would appear to be an useful tool for diagnosis and follow-up of MEO, highlighting the site and extension of the inflammatory process, and evaluating course and treatment efficacy. Tc-Sulesomab shows promise as a rapid, effective and safe imaging agent for treatment response evaluation and follow-up of patients with MEO. Further studies are warranted to validate the inclusion of Tc-Sulesomab scan in the imaging follow-up of patients with MEO. [ABSTRACT FROM AUTHOR]